Core Points - Yifeng Pharmacy Chain Co., Ltd. is established as a joint-stock company in accordance with the Company Law and Securities Law of the People's Republic of China [1][2] - The company was approved for public offering of 40 million shares and listed on the Shanghai Stock Exchange on February 17, 2015 [1][2] - The registered capital of the company is RMB 1,212,432,297 [2][4] Chapter 1: General Provisions - The purpose of the articles is to protect the legal rights of the company, shareholders, employees, and creditors [1] - The company is registered in Changde City, Hunan Province, with a business license number of 430700000011314 [1][2] - The chairman serves as the legal representative of the company, and the company must appoint a new legal representative within 30 days if the current one resigns [2][3] Chapter 2: Business Objectives and Scope - The company's business objective is to provide valuable goods and services for human health [4] - The business scope includes food sales, drug retail, medical services, and various other health-related services [4][5] Chapter 3: Shares - The company's shares are issued in the form of stocks, with a total of 1,212,432,297 shares, all of which are ordinary shares with a par value of RMB 1 [7][18] - The issuance of shares follows principles of openness, fairness, and justice, ensuring equal rights for all shareholders of the same class [7][8] - The company can increase capital through various methods, including issuing shares to unspecified objects or existing shareholders [20][21] Chapter 4: Shareholders and Shareholder Meetings - Shareholders have rights to dividends, attend meetings, supervise the company, and access company documents [12][13] - The company must hold an annual general meeting within six months after the end of the previous fiscal year [46] - Shareholders holding more than 10% of shares can request a temporary shareholder meeting [52][53] Chapter 5: Board of Directors - The board of directors is responsible for the company's operations and must report to the shareholders [72] - Directors must act in the best interest of the company and its shareholders, adhering to legal and regulatory requirements [40][41] - The board must ensure that the company maintains its independence and integrity in operations [41][42]
益丰药房: 公司章程(2025年7月修订)